Convertible Notes for Startups: When and Why Investors Use Them (2026)

Convertible notes are short-term debt instruments that let founders and investors close a round before setting a firm valuation. They're most useful in bridge financings and cross-border raises, though SAFEs have replaced them for most pre-seed deals in the U.S. This guide covers where they still fit in 2026, what the key terms mean and the dilution traps that catch founders off guard.

What Is a Convertible Note?

A convertible note is short-term debt that converts into equity at a future financing event. The company takes on a loan with the mutual expectation that it will convert into shares when the next priced round closes rather than being repaid in cash. Four components define every convertible note: principal amount, interest rate, maturity date and conversion mechanics, usually a valuation cap, a discount or both.

Understanding where convertible notes came from matters because their original purpose still influences how they work today. Investors originally designed convertible notes for bridge financings rather than seed financings.

The notes went to companies already in VC portfolios, helping them survive until the next priced round. Startups later adopted them for initial raises because the paperwork was lighter than a full equity financing. The instrument still carries structural features from that bridge-loan DNA.

Convertible Notes vs. Simple Agreements for Future Equity (SAFEs)

SAFEs emerged in 2013 as a seed stage response to convertible note friction. SAFEs strip away the two debt-like features that create the most founder risk: the maturity date and accruing interest. U.S. law treats SAFEs as equity instruments, not debt. The economic mechanics of caps and discounts work the same way in both instruments, but a SAFE won't put you in technical default if your next round takes longer than expected.

How Convertible Notes Differ From Priced Rounds

Priced equity rounds require setting an actual company valuation and issuing preferred stock at a defined per-share price. They're the most structured option and give both founders and investors the clearest picture of ownership.

The tradeoff is time and cost: priced rounds involve significantly more legal work and negotiation than either SAFEs or convertible notes, which is why most founders at the earliest stages reach for one of the convertible instruments first.

Where Convertible Notes Fit in 2026

The fundraising instrument market has shifted over the past two years. Understanding where convertible notes sit in 2026 requires looking at three distinct stages, as the instrument plays a completely different role at each. SAFEs dominate early rounds while convertible notes have consolidated into a narrower, but persistent niche.

The Pre-Seed Picture

SAFEs now dominate pre-seed fundraising by a wide margin. By Q1 2025, 90 percent of pre-seed deals used SAFEs, and convertible notes made up roughly 10 percent. The shift has been structural rather than temporary.

The Seed Stage Split

The seed stage tells a more nuanced story. Roughly 64 percent of seed deals use SAFEs, 27 percent use priced equity and about 10 percent use convertible notes. Deal size is the strongest predictor of instrument choice: seed rounds under $500,000 lean heavily toward SAFEs, while rounds over $5 million flip to 70 percent priced equity.

The threshold for transitioning to a priced round has moved upward, with a majority of rounds at $3 to $4 million in the first half of 2025 still raised on convertible instruments rather than priced equity.

The Bridge Financing Role

Convertible notes have consolidated into one primary surviving role: bridge financing for post-seed companies navigating uncertain valuation environments. Median post-seed convertible note bridge round sizes climbed to new highs through 2025. Early stage companies in 2024 continued to raise capital through SAFEs, notes and priced equity rounds.

Key Terms Every Founder Should Know

The economic terms in a convertible note determine how much of your company you'll give up when the note converts. These aren't abstract concepts. Each one directly affects your cap table at Series A.

Valuation Cap

The valuation cap is the maximum valuation at which the note converts into equity. If your Series A prices above the cap, the noteholder converts as though the company were valued at the cap and receives more shares per dollar than new investors.

Once you include a cap, it effectively becomes the de facto valuation for that financing, which raises a genuine question: if you're setting an implied valuation anyway, would a priced round give both sides more clarity? For pre-seed rounds under $250,000, the median cap sat at $7.5 million in Q2 2025.

Discount Rate

The discount rate gives early investors a percentage reduction on the share price paid by investors in the next priced round. If Series A investors pay $1.00 per share and your note carries a 20 percent discount, the noteholder converts at $0.80 per share. When a note includes both a cap and a discount, the investor converts under whichever provision yields the greater benefit to them.

In full-year 2025 data, roughly 61 percent of SAFEs used a valuation cap with no discount, the dominant structure by a wide margin.

Interest Rate

A convertible note is legally treated as debt, which means it must bear an interest rate. Interest accrues over the note's life and adds to the principal that converts to equity. This is the feature that most distinguishes convertible notes from SAFEs, which pay no interest. You can set the rate below the Applicable Federal Rate published by the Internal Revenue Service, but doing so can trigger imputed-interest tax consequences, so some accrual is often effectively non-negotiable. In practice, convertible note interest rates in 2025 generally remained modest rather than punitive.

Maturity Date

The maturity date is the deadline by which the note must either convert through a qualifying financing round or be repaid as cash. A note that reaches maturity without conversion puts the company in technical default and gives the investor the contractual right to demand repayment. Most pre-seed notes give companies at least a year before maturity. The most common practical outcome when a note approaches maturity is a negotiated extension, but the founder enters that negotiation from a position of weakness.

When Investors Prefer Convertible Notes

SAFEs are the default for most early stage deals in 2026, but convertible notes still serve specific investor needs that SAFEs can't replicate. Understanding the investor's reasoning helps you negotiate from a more informed position. These preferences tend to cluster around three scenarios:

1. Debt Seniority as Downside Protection

A convertible note is legally debt, which means it sits senior to equity in a liquidation scenario. Investors who prioritize capital recovery in downside outcomes have a structural basis for preferring notes over SAFEs. SAFEs are not debt instruments, so they generally avoid features like interest, maturity dates and repayment obligations, which is part of why they're often considered more founder-friendly. This preference has most often emerged among investors who have experienced portfolio losses and want structural protection on new checks.

2. Bridge Financing Between Priced Rounds

The note's maturity date, which creates risk at the pre-seed stage, functions as a useful accountability mechanism in the bridge context. An existing investor bridging a company to its next priced round wants a defined timeline. The maturity pressure reflects the instrument's original design context, and both sides benefit from clear expectations about when the next round should close. This helps explain why convertible notes remain common in post-seed bridge activity, even as SAFEs dominate initial raises.

3. International Investor Preferences

Convertible loans are the standard early stage instrument in European markets. SAFEs are an American invention, and European investors generally don't recognize or work with them because their legal frameworks have direct analogs only for convertible loans. If you're raising from European limited partners or angel investors, expect a preference for notes over SAFEs regardless of what the U.S. market data shows.

How Convertible Notes Create Hidden Dilution at Series A

The economic complexity of convertible notes catches founders in specific, predictable ways. Most of these traps involve dilution dynamics that don't become apparent until Series A, by which point it's too late to renegotiate. Knowing them in advance is the best protection.

The Maturity Date Trap

Convertible notes carry a maturity date, and if a qualifying financing hasn't closed by that date, the note's treatment depends on its terms, often involving repayment, conversion or an extension. Maturity risk is one of the most widely cited dangers of convertible notes: if a note hasn't been converted by the maturity date, the company probably doesn't have the money to cover the repayment obligation and the founder ends up in technical default.

When a founder returns to noteholders asking for an extension, the investor may extract higher interest rates, lower valuation caps or warrants as conditions. Founders should target a maturity date of at least 24 months. It frequently takes companies that long after a seed round to close a qualifying financing.

Stacking Multiple Notes

Founders who raise sequential convertible note rounds, each with different valuation caps, discount rates and interest accrual start dates, face a dilution event at Series A that's far more complex than they often anticipate. Three notes with three different caps produce three different per-share conversion prices at a single Series A event. The actual dilution depends on the Series A price in ways that most founders don't model until it's too late.

A large overhang of convertible debt from numerous note rounds can make it genuinely difficult to run a competitive Series A process, even when business fundamentals are strong.

Setting the Wrong Valuation Cap

Caps that are too low cause founders to absorb steep dilution when the note converts at Series A. If your cap is $10 million and your Series A prices at $20 million, the noteholder is effectively paying half price for shares. Signed contracts leave founders with little room to renegotiate.

A cap set too high creates the opposite problem: an implied valuation benchmark that your metrics can't support when you reach Series A, which can result in a down round or an inability to raise at all. This tension has become more acute in 2026, particularly for artificial intelligence (AI) companies, where seed rounds at high post-money valuations have become common. The "right" cap depends on where you realistically expect to be at Series A, not where you are today.

Convertible notes: The 2026 Market Context

Two broader market forces are shaping how founders and investors approach convertible instruments right now. Both affect your negotiating position directly. Understanding these dynamics helps you anticipate what investors will push for at the table.

Fewer Institutional Seed Leads

A priced equity round at seed often involves a lead investor willing to anchor the valuation. The supply of those leads has contracted significantly. First-time fund managers raised less capital meaningfully in the first half of 2025 than in prior years, on pace for a sharp year-over-year decline in fundraising activity. SAFEs and convertible notes don't require a lead investor to anchor a valuation, which makes convertible instruments structurally more accessible in a market with fewer seed stage leads. This reality is part of why the ability to reach a "yes" in 24 hours and lead rounds with conviction has become more valuable for founders who need speed and certainty.

Falling Interest Rates

During the higher-rate environment, convertible notes' mandatory coupon rate gave investors some additional yield while they waited for conversion. That driver has weakened. By early 2026, the rate environment had become more favorable than during the 2022 to 2023 period. This is directionally consistent with the continued shift toward SAFEs, as notes' interest accrual and maturity features have become less compelling relative to SAFEs for many early stage financings.

Choosing the Right Instrument

The choice between a convertible note, a SAFE and a priced round isn't about which instrument is "best" in the abstract. It depends on your specific situation. One important point is that SAFEs eliminate the debt mechanics of convertible notes, but they don't eliminate the economic complexity of caps, discounts and conversion math.

The right answer depends less on theory and more on your stage, investor mix and whether you're setting a valuation now or later. Here is a practical way to think about this choice:

• SAFE: You're raising your first outside capital in the U.S. at pre-seed. Over 90 percent of pre-seed deals use SAFEs, and the absence of maturity dates and interest accrual makes them the most founder-friendly option at this stage.
  
  
• Convertible note: You're bridging between two priced rounds, raising from European investors or working with investors who want debt seniority as downside protection. The maturity date creates useful accountability in the bridge context it was designed for.
  
  
• Priced round: You have a clear lead investor, meaningful traction and the metrics to support a valuation conversation. Larger rounds often lean toward priced equity, and the clarity of defined ownership benefits both sides.
  
  

The instrument should fit the financing in front of you, not the one you see most often in the market. That framing helps founders decide when simplicity is the priority and when structure is worth the extra work.

If you're an early stage founder looking for a lead investor who moves with speed and conviction, reach out to us to see if we'd be a good fit.

Frequently Asked Questions

What is a convertible note in startup fundraising?

A convertible note is short-term debt that converts into equity when a startup raises its next priced financing round. The note carries an interest rate and a maturity date, along with conversion mechanics like a valuation cap or discount that reward early investors for taking on greater risk. Both parties usually intend conversion rather than cash repayment, but the maturity date creates a legal obligation to repay if conversion hasn't occurred by the deadline.

Should a first-time founder use a convertible note or a SAFE?

For most U.S.-based founders raising their first outside capital, a SAFE is the more common and often more founder-friendly choice. SAFEs eliminate the maturity date, which can create repayment pressure and interest accrual, which adds to dilution. Convertible notes are a better fit when you're bridging between priced rounds or working with investors who specifically require debt seniority.

How much dilution should a founder expect from a convertible note at seed stage?

Dilution at seed varies meaningfully by round structure, market conditions and your actual dilution depends on the valuation cap, discount rate, interest accrual and how long the note is outstanding before conversion. Founders who stack multiple notes with different caps often face more dilution at Series A than they modeled. The most effective protection is modeling your full cap table at conversion across multiple Series A price scenarios before signing each note.

When do investors choose convertible notes over SAFEs in 2026?

Investors may prefer convertible notes in certain scenarios, such as bridge financings between rounds, when some investors want debt protections and in some cross-border financings. Outside of these situations, most early stage investors in the U.S. default to SAFEs.

‍